Randomized Study to Evaluate the Safety and Efficacy of INCB013739 Plus Metformin Compared to Metformin Alone on Glycemic Control in Type 2 Diabetic Subjects.
Phase of Trial: Phase II
Latest Information Update: 15 Feb 2018
At a glance
- Drugs INCB 13739 (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 02 Oct 2009 Results presented at the 45th Annual Meeting of the European Association for the Study of Diabetes (EASD).
- 02 Oct 2009 Primary endpoint 'Proportion of glycosylated haemoglobin' has been met according to results presented at the 45th Annual Meeting of the European Association for the Study of Diabetes.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History